| 期 |
标题 |
文件 |
| 卷 30, 编号 38 (2024) |
Exploring the Biomarkers and Potential Mechanisms of Botulinum Toxin Type A in the Treatment of Microglial Inflammatory Activation through P2X7 Receptors based on Transcriptome Sequencing |
(Eng)
|
|
Zhang K., Ren Y., Lv J., Mao P., Zhou W., Shi Y., Zhou K., Wang L., Zhang C., Zhang H.
|
| 卷 30, 编号 3 (2024) |
Exploring the Effect of Xiao-Chai-Hu Decoction on Treating Psoriasis Based on Network Pharmacology and Experiment Validation |
(Eng)
|
|
He K., Wang Z., Liu M., Du W., Yin T., Bai R., Duan Q., Wang Y., Lei H., Zheng Y.
|
| 卷 30, 编号 26 (2024) |
Exploring the Mechanism of Zhishi-Xiebai-Guizhi Decoction for the Treatment of Hypoxic Pulmonary Hypertension based on Network Pharmacology and Experimental Analyses |
(Eng)
|
|
Huang P., Wang Y., Liu C., Zhang Q., Ma Y., Liu H., Wang X., Wang Y., Wei M., Ma L.
|
| 卷 30, 编号 24 (2024) |
Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic Reprogramming of Hepatocellular Carcinoma: A Study based on Network Pharmacology, Molecular Docking and Bioinformatics |
(Eng)
|
|
Wan Y., Jiang H., Liu Z., Bai C., Lian Y., Zhang C., Zhang Q., Huang J.
|
| 卷 30, 编号 29 (2024) |
Exploring the Therapeutic Potential of Triptonide in Salivary Adenoid Cystic Carcinoma: A Comprehensive Approach Involving Network Pharmacology and Experimental Validation |
(Eng)
|
|
Geng S., Chen L., Lin W., Wan F., Le Z., Hu W., Chen H., Liu X., Huang Q., Zhang H., Lu J., Kong L.
|
| 卷 30, 编号 1 (2024) |
Foreword |
(Eng)
|
|
Antonelli A.
|
| 卷 30, 编号 3 (2024) |
Free Radicals, Mitochondrial Dysfunction and Sepsis-induced Organ Dysfunction: A Mechanistic Insight |
(Eng)
|
|
Kumar S., Srivastava V., Kaushik S., Saxena J., Jyoti A.
|
| 卷 30, 编号 2 (2024) |
GLP-1/GLP-1RAs: New Options for the Drug Treatment of NAFLD |
(Eng)
|
|
Jiang H., Zang L.
|
| 卷 30, 编号 31 (2024) |
Green Synthesis of Silver Nanoparticles and their Potential Applications in Mitigating Cancer |
(Eng)
|
|
Mir R., Maqbool M., Mir P., Hussain M., din Wani S., Pottoo F., Mohi-ud-din R.
|
| 卷 30, 编号 20 (2024) |
Green Synthesis of Silver Nanoparticles using Cirsium congestum Extract Modified by Chitosan/Alginate: Bactericidal Activity against Pathogenic Bacteria and Cytotoxicity Analysis in Normal Cell Line |
(Eng)
|
|
Mohtashami M., Rezagholizade-Shirvan A., Hojati Bonab Z., Amiryousefi M., Darroudi M., Ahmadi Solimani M., Yaghoobi S., Dolatabadi S., Ghasemi A., Momtazi-Borojeni A.
|
| 卷 30, 编号 28 (2024) |
Hua-Feng-Dan Alleviates LPS-induced Neuroinflammation by Inhibiting the TLR4/Myd88/NF-κB Pathway: Integrating Network Pharmacology and Experimental Validation |
(Eng)
|
|
Zhang Z., Pei Y., Zheng Y., Liu Y., Guo Y., He Y., Cheng F., Wang X.
|
| 卷 30, 编号 34 (2024) |
Huangqi Guizhi Wuwu Decoction Improves Inflammatory Factor Levels in Chemotherapy-induced Peripheral Neuropathy by Regulating the Arachidonic Acid Metabolic Pathway |
(Eng)
|
|
Wang S., Du X., Yan G., Yang L., Sun H., Zhang X., Kong L., Han Y., Han D., Tang S., Wang X.
|
| 卷 30, 编号 4 (2024) |
Human Data on Pharmacokinetic Interactions of Cannabinoids: A Narrative Review |
(Eng)
|
|
Maldonado C., Peyraube R., Fagiolino P., Oricchio F., Cuñetti L., Vázquez M.
|
| 卷 30, 编号 14 (2024) |
Identification of Drug Targets and Agents Associated with Ferroptosis-related Osteoporosis through Integrated Network Pharmacology and Molecular Docking Technology |
(Eng)
|
|
Huo K., Yang Y., Yang T., Zhang W., Shao J.
|
| 卷 30, 编号 36 (2024) |
Identification of Peptidoglycan Glycosyltransferase FtsI as a Potential Drug Target against Salmonella Enteritidis and Salmonella Typhimurium Serovars Through Subtractive Genomics, Molecular Docking and Molecular Dynamics Simulation Approaches |
(Eng)
|
|
Gulzar I., Khalil A., Ashfaq U., Liaquat S., Haque A.
|
| 卷 30, 编号 40 (2024) |
Immune-mediated Bowel Disease: Role of Intestinal Parasites and Gut Microbiome |
(Eng)
|
|
Chowdhury S., Dey A., Gautam M., Mondal S., Pawar S., Ranade A., Bora M., Gangwar M., Teli A., Mondal N.
|
| 卷 30, 编号 24 (2024) |
Impact of Bioactive Compounds in the Management of Various Inflammatory Diseases |
(Eng)
|
|
Babbar R., Kaur A., Vanya ., Arora R., Gupta J., Wal P., Tripathi A., Koparde A., Goyal P., Ramniwas S., Gulati M., Behl T.
|
| 卷 30, 编号 17 (2024) |
Impact of Combination Therapy with Chemical Drugs and Megavoltage X-ray Exposure on Breast Cancer Stem Cells Viability and Proliferation of MCF-7 and MDA-MB-231 Cell Lines |
(Eng)
|
|
Banisharif Dehkordi F., Ghatrehsamani M., Abdolvand M., Soltani A., Masoumi S.
|
| 卷 30, 编号 33 (2024) |
Impact of Tyrosine Kinase Inhibitors (TKIs) on Growth in Children and Adolescents with Chronic Myeloid Leukemia: A Systematic Review |
(Eng)
|
|
Katsarou D., Kotanidou E., Tsinopoulou V., Tragiannidis A., Hatzipantelis E., Galli-Tsinopoulou A.
|
| 卷 30, 编号 28 (2024) |
In vitro Effect of Cannabidiol on Red Blood Cells: Implication in Long-Lasting Pathology Treatment |
(Eng)
|
|
Gómez C., Borda N., Moscovicz F., Fernandez F., Lazarowski A., Auzmendi J.
|
| 卷 30, 编号 18 (2024) |
In vitro Modified Release Studies on Melatoninergic Fluorinated Phenylalkylamides: Circumventing their Lipophilicity for Oral Administration |
(Eng)
|
|
Vlachou M., Siamidi A., Protopapa C., Vlachos M., Kloutsou S., Dreliozi C., Papanastasiou I.
|
| 卷 30, 编号 21 (2024) |
In-depth Exploration of the Basics of Microfluidic Cell Deformability to Unveil its Applications in the Modern Era |
(Eng)
|
|
Rani P., Nanda B., Bhatia R.
|
| 卷 30, 编号 14 (2024) |
Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness: Mechanisms and Future Outlook |
(Eng)
|
|
Verma A., Awasthi A.
|
| 卷 30, 编号 42 (2024) |
Integrating Network Pharmacology, Bioinformatics, and Mendelian Randomization Analysis to Identify Hub Targets and Mechanisms of Kunkui Baoshen Decoction in Treating Diabetic Kidney Disease |
(Eng)
|
|
Song S., Yu J.
|
| 卷 30, 编号 30 (2024) |
Intelligent Systems based on Cyclodextrins for the Treatment of Breast Cancer |
(Eng)
|
|
Nunes A., de Oliveira Alves Júnior J., Haydée V., Júnior J.
|
| 卷 30, 编号 5 (2024) |
Interplay between LncRNA/miRNA and TGF-β Signaling in the Tumorigenesis of Gynecological Cancer |
(Eng)
|
|
Safavi P., Moghadam K., Haghighi Z., Ferns G., Rahmani F.
|
| 卷 30, 编号 3 (2024) |
Interplay of G-proteins and Serotonin in the Neuroimmunoinflammatory Model of Chronic Stress and Depression: A Narrative Review |
(Eng)
|
|
Gusev E., Sarapultsev A.
|
| 卷 30, 编号 13 (2024) |
Investigating Bacopa monnieri L. Therapeutic Potential for the Treatment of Neurological Diseases |
(Eng)
|
|
Srivastava P., Yadav D., Singh S., Kim S., Singh S., Katiyar S., Song M.
|
| 卷 30, 编号 32 (2024) |
Key Challenges, Influencing Factors, and Future Perspectives of Nanosuspensions in Enhancing Brain Drug Delivery |
(Eng)
|
|
Wang W., Yang C., Xue L., Wang Y.
|
| 卷 30, 编号 28 (2024) |
Leveraging Artificial Intelligence for Synergies in Drug Discovery: From Computers to Clinics |
(Eng)
|
|
Arora P., Behera M., Saraf S., Shukla R.
|
| 卷 30, 编号 17 (2024) |
Lipase and Protease Production Ability of Multi-drug Resistant Bacteria Worsens the Outcomes of Wound Infections |
(Eng)
|
|
Rahman A., Sardar S., Niaz Z., Khan A., Sheheryar S., Alrefaei A., Hamayun M., Ali S.
|
| 卷 30, 编号 27 (2024) |
Long Non-coding RNAs Regulating Macrophage Polarization in Liver Cancer |
(Eng)
|
|
Jia D., He Y., Zhang Y.
|
| 卷 30, 编号 6 (2024) |
LSTM-SAGDTA: Predicting Drug-target Binding Affinity with an Attention Graph Neural Network and LSTM Approach |
(Eng)
|
|
Qiu W., Liang Q., Yu L., Xiao X., Qiu W., Lin W.
|
| 卷 30, 编号 34 (2024) |
Lycium barbarum Ameliorates Oral Mucositis via HIF and TNF Pathways: A Network Pharmacology Approach |
(Eng)
|
|
Chen X., Wu Y., Li J., Jiang S., Sun Q., Xiao L., Jiang X., Xiao X., Li X., Mu Y.
|
| 卷 30, 编号 11 (2024) |
Machine-learning-guided Directed Evolution for AAV Capsid Engineering |
(Eng)
|
|
Fu X., Suo H., Zhang J., Chen D.
|
| 卷 30, 编号 39 (2024) |
Magnesium (Mg2+): Essential Mineral for Neuronal Health: From Cellular Biochemistry to Cognitive Health and Behavior Regulation |
(Eng)
|
|
Kumar A., Mehan S., Tiwari A., Khan Z., Gupta G., Narula A., Samant R.
|
| 卷 30, 编号 1 (2024) |
Marein Ameliorates Myocardial Fibrosis by Inhibiting HIF-1α and TGF-β1/Smad2/3 Signaling Pathway in Isoproterenol-stimulated Mice and TGF-β1-stimulated Cardiac Fibroblasts |
(Eng)
|
|
Niu G., Zhao Y., Song H., Song Q., Yin X., Zhu Z., Xu J.
|
| 卷 30, 编号 29 (2024) |
Matrine-loaded Nano-liposome Induces Apoptosis in Human Esophageal-squamous Carcinoma KYSE-150 Cells |
(Eng)
|
|
Zhao K., Cai Y., Raza F., Zafar H., Pan L., Zheng X., Xu W., Li R., Shi F., Ma Y.
|
| 卷 30, 编号 32 (2024) |
Maximizing Treatment Options for IBD through Drug Repurposing |
(Eng)
|
|
Barjasteh A., Al-Asady A., Latifi H., Al Okla S., Al-Nazwani N., Avan A., Khazaei M., Ryzhikov M., Nadi-Yazdi H., Hassanian S.
|
| 卷 30, 编号 39 (2024) |
Mechanism of Action of NvZhen ErXian HeJi in Ovariectomized Rats with Myocardial Infarction based on Network Pharmacology |
(Eng)
|
|
Wu K., Guo S., Zhang J., Wen D., Zhang L., Zhu M., Wang X., Li X., Chen Z., Lin F.
|
| 卷 30, 编号 25 (2024) |
Mechanism of Preventing Recurrence of Stage II-III Colorectal Cancer Metastasis with Immuno-inflammatory and Hypoxic Microenvironment by a Four Ingredients Chinese Herbal Formula: A Bioinformatics and Network Pharmacology Analysis |
(Eng)
|
|
Shi C., Liu X., Han S., Tang Y., Zeng H., Du M., Yang Y., Jia J., Shi Q., Hou F.
|
| 卷 30, 编号 16 (2024) |
Mechanism Research of PZD Inhibiting Lung Cancer Cell Proliferation, Invasion, and Migration based on Network Pharmacology |
(Eng)
|
|
Feng F., Hu P., Peng L., Chen J., Tao X.
|
| 卷 30, 编号 38 (2024) |
Mechanisms Underlying the Therapeutic Effects of Nicotinamide Mononucleotide in Treating High-fat Diet-induced Hypertrophic Cardiomyopathy based on GEO Datasets, Network Pharmacology, and Molecular Docking |
(Eng)
|
|
Han Y., Wang L., Zhang Y., Zhou A., Wang Z., Dong W., Wang J., Wang T., Zou J.
|
| 卷 30, 编号 13 (2024) |
Medicinal Plant-derived Phytochemicals in Detoxification |
(Eng)
|
|
Bjørklund G., Cruz-Martins N., Goh B., Mykhailenko O., Lysiuk R., Shanaida M., Lenchyk L., Upyr T., Rusu M., Pryshlyak A., Shanaida V., Chirumbolo S.
|
| 卷 30, 编号 37 (2024) |
Methodological Approaches for Increasing the Retroviral Transduction Efficiency of Primary NK Cells |
(Eng)
|
|
Streltsova M., Palamarchuk A., Vavilova J., Ustiuzhanina M., Boyko A., Velichinskii R., Alekseeva N., Grechikhina M., Shustova O., Sapozhnikov A., Kovalenko E.
|
| 卷 30, 编号 22 (2024) |
MicroRNAs as Key Regulators in RA and SLE: Insights into Biological Functions |
(Eng)
|
|
Li X., Zhao C., Wei H., Li S., Tang J., Zhu Y., Cheng X., Shi Q., Wang P., Pan H.
|
| 卷 30, 编号 15 (2024) |
Molecular Mechanisms of Medicinal Plant Securinega suffruticosa-derived Compound Securinine against Spinal Muscular Atrophy based on Network Pharmacology and Experimental Verification |
(Eng)
|
|
Zhang Y., He J., Xiang L., Tang X., Wang S., Li A., Wang C., Li L., Zhu B.
|
| 卷 30, 编号 26 (2024) |
Multi-stimuli-responsive Hydrogels for Therapeutic Systems: An Overview on Emerging Materials, Devices, and Drugs |
(Eng)
|
|
Garshasbi H., Soleymani S., Naghib S., Mozafari M.
|
| 卷 30, 编号 41 (2024) |
Murraya koenigii (L.) Spreng. as a Natural Intervention for Diabesity: A Review |
(Eng)
|
|
Jachak S., Thakur M., Ahirrao P., Goyal A.
|
| 卷 30, 编号 5 (2024) |
N-Acylhydrazone Pharmacophore's Analgesic and Anti-inflammatory Profile: Recent Advancements during the Past Ten Years |
(Eng)
|
|
Kassab A.
|
| 卷 30, 编号 1 (2024) |
Nanocomposite Hydrogels-A Promising Approach towards Enhanced Bioavailability and Controlled Drug Delivery |
(Eng)
|
|
Shahid N., Erum A., Hanif S., Malik N., Tulain U., Syed M.
|
| 卷 30, 编号 28 (2024) |
Nanofabrication of Losartan Potassium Sustained Release Floating Microspheres using Different Grades of Ethyl Cellulose and its Insight on Release Profiles |
(Eng)
|
|
Rajput T., Mohite P., Ghule S., Vinchurkar K., Singh S.
|
| 卷 30, 编号 38 (2024) |
Nanomaterials in Targeting Cancer Cells with Nanotherapeutics: Transitioning Towards Responsive Systems |
(Eng)
|
|
Jain B., Verma D., Rawat R., Berdimurodov E.
|
| 卷 30, 编号 33 (2024) |
Nanotechnological Advances in the Diagnosis of Gynecological Cancers and Nanotheranostics |
(Eng)
|
|
Keyvani V., Mollazadeh S., Riahi E., Mahmoudian R., Anvari K., Avan A.
|
| 卷 30, 编号 19 (2024) |
Nanotechnology in Orthodontics: Unveiling Pain Mechanisms, Innovations, and Future Prospects of Nanomaterials in Drug Delivery |
(Eng)
|
|
Sharma D., Kumar S., Garg Y., Chopra S., Bhatia A.
|
| 卷 30, 编号 42 (2024) |
Naringin Affects Caspase-3, IL-1β, and HIF-1α Levels in Experimental Kidney Ischemia-Reperfusion in Rats |
(Eng)
|
|
Danis E., Acar G., Dasdelen D., Solmaz M., Mogulkoc R., Baltaci A.
|
| 卷 30, 编号 31 (2024) |
Nephroprotective Effect of Ferula assa-foetida Oleo Gum Resin on Type 2 Diabetic Rats |
(Eng)
|
|
Bagheri S., Hakimizadeh E., Allahtavakoli M.
|
| 卷 30, 编号 12 (2024) |
Network Pharmacology along with Molecular Docking to Explore the Mechanism of Danshen Injection against Anthracycline-induced Cardiotoxicity and Transcriptome Validation |
(Eng)
|
|
Dai Q., Pan Y., Zhu X., Chen M., Xie L., Zhu Y., Wan G.
|
| 卷 30, 编号 42 (2024) |
Network Pharmacology Analysis and Retrospective Cohort Study Revealing the Effect of Qingyi Decoction on Intestinal Paralysis in Patients with Severe Acute Pancreatitis |
(Eng)
|
|
Du S., Zhao D., Song K., Zhang Y., Wu L., Wang B., Li Y., Yu J.
|
| 卷 30, 编号 9 (2024) |
Network Pharmacology Analysis on the Mechanism of Xihuangwan in Treating Rectal Cancer and Radiation Enteritis |
(Eng)
|
|
Lv M., Ding R., Ma P., Feng Y., Zeng S., Zhang Y., Shen W., Guan W., E. X., Zeng H., Yu J.
|
| 卷 30, 编号 4 (2024) |
Network Pharmacology and In vitro Experimental Verification to Explore the Mechanism of Chaiqin Qingning Capsule in the Treatment of Pain |
(Eng)
|
|
Gao H., Chen Z., Halihaman B., Huang L., Wang Z., Ding X.
|
| 卷 30, 编号 28 (2024) |
Network Pharmacology and Molecular Docking Validation to Explore the Pharmacological Mechanism of Zhuling Decoction against Nephrotic Syndrome |
(Eng)
|
|
Su S., Zhang Q., Zhang L., Chen N., Chu Y.
|
| 卷 30, 编号 18 (2024) |
Network Pharmacology Combined with Molecular Docking Approach to Investigate the Mechanism of ChuShiWeiLing Decoction against Perianal Eczema |
(Eng)
|
|
Liu Y., Hao M., Fang X., Qian Y., Wang Y., Yan S.
|
| 卷 30, 编号 17 (2024) |
Network Pharmacology, Molecular Docking Analysis and Molecular Dynamics Simulation of Scutellaria baicalensis in the Treatment of Liver Fibrosis |
(Eng)
|
|
Wang J., Wu Z., Chen X., Sun Y., Ma S., Weng J., Zhang Y., Dong K., Shao J., Zheng S.
|
| 卷 30, 编号 17 (2024) |
Network Pharmacology Study on Herb Pair Bletilla striata-Galla chinensis in the Treatment of Chronic Skin Ulcers |
(Eng)
|
|
Wang Y., Ding T., Jiang X.
|
| 卷 30, 编号 35 (2024) |
Network Pharmacology to Reveal the Mechanism of Fufang Banmao Capsule for Treating Unresectable Primary Liver Cancer and Clinical Data Validation |
(Eng)
|
|
Hu Y., Xiao Y., Wan L., Wen Z.
|
| 卷 30, 编号 17 (2024) |
Neuropilin-1 Binding Peptide as Fusion to Diphtheria Toxin Induces Apoptosis in Non-small Cell Lung Cancer Cell Line |
(Eng)
|
|
Eghtedari S., Behdani M., Kazemi-Lomedasht F.
|
| 卷 30, 编号 2 (2024) |
Neuro-protective Effect of Acetyl-11-keto-β-boswellic Acid in a Rat Model of Scopolamine-induced Cholinergic Dysfunction |
(Eng)
|
|
Assaran A., Hosseini M., Shirazinia M., Eshaghi Ghalibaf M., Beheshti F., Mobasheri L., Mirzavi F., Rajabian A.
|
| 卷 30, 编号 32 (2024) |
New Insights in Psoriasis Management using Herbal Drug Nanocarriers |
(Eng)
|
|
Salgaonkar S., Purewal J., Doshi G., Fernandes T., Gharat S., Sawarkar S.
|
| 卷 30, 编号 25 (2024) |
Nicotine-induced Genetic and Epigenetic Modifications in Primary Human Amniotic Fluid Stem Cells |
(Eng)
|
|
Upadhyaya P., Milillo C., Bruno A., Anaclerio F., Buccolini C., DellElice A., Angilletta I., Gatta M., Ballerini P., Antonucci I.
|
| 卷 30, 编号 21 (2024) |
Niosomes as a Promising Therapeutic Approach against Colorectal Cancer: A Focus on the Delivery of Chemotherapeutics and Natural Products |
(Eng)
|
|
Ryzhikov M., Hassanian S., Mollazadeh S., Al-Asady A., Barjasteh A., Latifi H., Avan A., Khazaei M.
|
| 卷 30, 编号 37 (2024) |
Nobiletin Regulates Polyinosinic-polycytidylic Acid-induced Inflammation in Macrophages Partially via the PPAR-γ Signaling Pathway |
(Eng)
|
|
Yue Y., Huang S., Weng Y., Lu Y., Jia B., Yang Z.
|
| 卷 30, 编号 2 (2024) |
Novel Arena of Nanocosmetics: Applications and their Remarkable Contribution in the Management of Dermal Disorders, Topical Delivery, Future Trends and Challenges |
(Eng)
|
|
Ahuja A., Bajpai M.
|
| 卷 30, 编号 29 (2024) |
Novel Therapies for ANCA-associated Vasculitis: Apilimod Ameliorated Endothelial Cells Injury through TLR4/NF-κB Pathway and NLRP3 Inflammasome |
(Eng)
|
|
Liu S., Cao C., Wang Y., Hu L., Liu Q.
|
| 卷 30, 编号 35 (2024) |
Optimization of Hypercholesterolemia Treatment after Heart Transplant: The Role of PCSK9 Inhibitors |
(Eng)
|
|
Jesus Valero-Masa M., Ortiz-Bautista C., Castrodeza J., Martinez-Selles M.
|
| 卷 30, 编号 7 (2024) |
Organogels: "GelVolution" in Topical Drug Delivery - Present and Beyond |
(Eng)
|
|
Shirur K., Pandey A., Mutalik S., Nikam A., Roy A., Raychaudhuri R., Navti P., Soman S., Kulkarni S.
|
| 卷 30, 编号 28 (2024) |
Overview of Spanlastics: A Groundbreaking Elastic Medication Delivery Device with Versatile Prospects for Administration via Various Routes |
(Eng)
|
|
Kumar L., Rana R., Kukreti G., Aggarwal V., Chaurasia H., Sharma P., Jyothiraditya V.
|
| 卷 30, 编号 21 (2024) |
Personalized Approaches to Cardiovascular Disease: Insights into FDA-Approved Interventions and Clinical Pharmacogenetics |
(Eng)
|
|
Raoufinia R., Rahimi H., Abbaszadeh M., Gholoobi A., Saburi E., Fakoor F., Alshakarchi H., Gataa I., Hassanian S., Ferns G., Khazaei M., Avan A.
|
| 卷 30, 编号 8 (2024) |
Pharmacological Considerations during Percutaneous Treatment of Heart Failure |
(Eng)
|
|
Sorolla-Romero J., Navarrete-Navarro J., Martinez-Sole J., Garcia H., Diez-Gil J., Martinez-Dolz L., Sanz-Sanchez J.
|
| 卷 30, 编号 24 (2024) |
Pharmacological Mechanism of Herbal Interventions for Bipolar Disorder |
(Eng)
|
|
Singh A., Sarwat M., Gupta S.
|
| 卷 30, 编号 21 (2024) |
Polypharmacy in Psychiatry: An In-depth Examination of Drug-drug Interactions and Treatment Challenges |
(Eng)
|
|
Shekho D., Mishra R., Kamal R., Khurana D., Chauhan A., Awasthi A.
|
| 卷 30, 编号 16 (2024) |
Preclinical Pharmacokinetics and Pharmacology Study of RC98: A Programmed Cell Death Ligand 1 Monoclonal Antibody in Cynomolgus Monkeys |
(Eng)
|
|
Li S., Dong L., Jiang J., Wang L., Li Q., Deng C., Liu Z., Wang F.
|
| 卷 30, 编号 40 (2024) |
Preparation and Characterization of Nanostructured Lipid Carriers (NLCs) Containing Glycyrrhiza glabra Extract for the Treatment of Skin Hyperpigmentation |
(Eng)
|
|
Hoseinsalari A., Atapour-Mashhad H., Asili J., Tayarani-Najaran Z., Mohtashami L., Khanavi M., Vazirian M., Akbari Javar H., Niknam S., Golmohammadzadeh S., Ardekani M.
|
| 卷 30, 编号 10 (2024) |
Preparation Optimization and Immunological Activity Studies of Portulaca oleracea L. Polysaccharides Liposomes |
(Eng)
|
|
Li Y., Jia G., Li T., Zhou X., Zhao H., Cao J., Guan Z., Zhao R.
|
| 卷 30, 编号 34 (2024) |
Prescription Precision: A Comprehensive Review of Intelligent Prescription Systems |
(Eng)
|
|
Tantray J., Patel A., Wani S., Kosey S., Prajapati B.
|
| 卷 30, 编号 24 (2024) |
Protective Effect and Related Mechanism of Modified Danggui Buxue Decoction on Retinal Oxidative Damage in Mice based on Network Pharmacology |
(Eng)
|
|
Hu X., Liu F., Yang H., Qi M., Ren Y., Zhu W., Dai C.
|
| 卷 30, 编号 18 (2024) |
Protective Effects and Mechanisms of Luteolin against Acute Respiratory Distress Syndrome: Network Pharmacology and In vivo and In vitro Studies |
(Eng)
|
|
Li Q., Chen J., Ren Y., Yang Z., Wang M., Zhang W., Cao L., Sun H., Nie S., Sun Z.
|
| 卷 30, 编号 21 (2024) |
Protective Effects of the Aqueous Extract of Malva sylvestris Plant against the Lethality and Histopathological Damage in Experimental Envenoming of Hemiscorpius lepturus Venom in Balb/c Mice |
(Eng)
|
|
Ahmadi S., Yousofpour M., Kamalinejad M., Otroshi A., Amiri F., Alipour A., Zareinejad M., Shahbazzadeh D.
|
| 卷 30, 编号 24 (2024) |
Qingxiong Ointment and its Active Ingredient, Shikonin Treat Psoriasis through HIF-1 Signaling Pathway |
(Eng)
|
|
Zhang B., Yan G., Li F., Tang Y., Xu G., Zhang Y., Ze K.
|
| 卷 30, 编号 6 (2024) |
Quality by Design Perspective for Designing Foam-based Formulation: Current State of Art |
(Eng)
|
|
Kumar M., Kumar D., Singh S., Chopra S., Mahmood S., Bhatia A.
|
| 卷 30, 编号 23 (2024) |
Reactive Oxygen Species and Mitochondrial Calcium's Roles in the Development of Atherosclerosis |
(Eng)
|
|
Priya H., Jha K., Kumar N., Singh S.
|
| 卷 30, 编号 16 (2024) |
Recent Advancements in Refashioning of NSAIDs and their Derivatives as Anticancer Candidates |
(Eng)
|
|
Kassab A., Gedawy E.
|
| 卷 30, 编号 19 (2024) |
Recent Advances in the Treatment Strategies of Friedreichs Ataxia: A Review of Potential Drug Candidates and their Underlying Mechanisms |
(Eng)
|
|
Saini A., Anil N., Vijay A., Mangla B., Javed S., Kumar P., Ahsan W.
|
| 卷 30, 编号 34 (2024) |
Recent Research Trends against Skin Carcinoma - An Overview |
(Eng)
|
|
Varshney K., Mazumder R., Rani A., Mishra R., Khurana N.
|
| 卷 30, 编号 6 (2024) |
Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel Delivery Systems of Chlorogenic Acid for the Management of Diseases with a Special Emphasis on Ulcerative Colitis |
(Eng)
|
|
Harwansh R., Bhati H., Deshmukh R.
|
| 卷 30, 编号 8 (2024) |
Relationship between Compound α-Ketoacid and Microinflammation in Patients with Chronic Kidney Disease |
(Eng)
|
|
Chen Z., Lin Y., Wang J., Yao K., Xie Y., Chen X., Zhou T.
|
| 卷 30, 编号 11 (2024) |
Remedial Dosing Recommendations for Sirolimus Delayed or Missed Dosages Caused by Poor Medication Compliance in Pediatric Tuberous Sclerosis Complex Patients |
(Eng)
|
|
Yang Y., Jiang L., Zhu H., Sun W., Mao J., Miao J., Wang Y., He S., Wang D., Chen X.
|
| 卷 30, 编号 11 (2024) |
Repurposing of Angiotensin-converting-enzyme Inhibitor on Prevention of Post-surgical Tendon Adhesion |
(Eng)
|
|
Naimi H., Khazaei M., Sharifnia F., Sayyed-Hosseinian S.
|
| 卷 30, 编号 12 (2024) |
Revisiting the Mitochondrial Function and Communication in Neurodegenerative Diseases |
(Eng)
|
|
Wankhede N., Kale M., Umare M., Lokhande S., Upaganlawar A., Wal P., Taksande B., Umekar M., Khandige P., Singh B., Sadananda V., Ramniwas S., Behl T.
|
| 卷 30, 编号 41 (2024) |
Revolutionizing Antiviral Therapeutics: In silico Approaches for Emerging and Neglected RNA Viruses |
(Eng)
|
|
Sharma K., Singh M., Sharma S.
|
| 101 - 200 的 257 信息 |
<< < 1 2 3 > >> |
